European medical authorities have been closely examining the link between Actos and Bladder Cancer for a number of years.  An editor for the Irish Medical Times summarized the findings of several studies and concluded that there is an increased risk between the use of Actos and Bladder Cancer:


There is a small increased risk of bladder cancer with the use of pioglitazone [Actos]; epidemiological data suggest a relative risk of around 1.2 (ranging from 1.15 to 1.33 for ever use across studies).  Source: Pioglitazone – New contra-indications and warnings — Irish Medical Times

Once again, the people with the highest risk of developing bladder cancer while taking Actos appear to be those who are taking the highest doses for the longest period of time.  People who have been taking Actos for one year or longer seem to be at the highest risk of developing bladder cancer.

Scientists at the FDA and at the European equivalents of the FDA are still examining data and looking at the link between Actos and bladder cancer.  However, the link at this time is strong enough that I’m currently accepting Actos cases.  Not sure if an Actos lawyer can help you?  Call or e-mail me and I’ll be happy to talk about your situation.